Incidence of dementia after a recent cancer diagnosis among people with HIV

ObjectiveTo evaluate risk of dementia after cancer diagnosis among Medicaid beneficiaries with HIV. DesignLongitudinal observational study of Medicaid enrollment, inpatient, and outpatient claims data from 14 states, 2001-2015. MethodsBeneficiaries aged 18-64 with HIV and [≥]6 months of enrollment were matched 1:1 on cancer status by age, sex, race, year, and state. We estimated the weighted cumulative incidence functions (CIFs) of dementia at 1, 2, and 5 years after cancer diagnosis using the Aalen-Johansen estimator to account for the competing risk of death and cluster stratified analyses to account for matching. We calculated the corresponding risk differences (RD) and 95% confidence intervals (CI) using nonparametric bootstrap. ResultsAt 5 years, the CIF of dementia was 9.6% (95%CI: 8.2, 11.6) and 4.7% (95%CI: 3.7, 6.1) among those with and without AIDS-defining cancer, respectively (RD: 4.9%; 95%CI: 2.9, 7.0). At 5 years, the CIF of dementia was 7.1% (95%CI: 5.9, 7.8) and 5.3% (95%CI: 4.2, 6.2) among those with and without non-AIDS-defining cancer, respectively (RD: 1.8%; 95%CI: 0.34, 2.9). Dementia incidence appeared higher among beneficiaries with lung cancer (2yr RD: 1.9%; 95%CI: 0.01, 5.2) and beneficiaries [≤]50 with colon cancer (2yr RD: 4%; 95%CI: 0.3, 10.5), but lower among beneficiaries [≤]50 with prostate cancer (2yr RD: -1.9%; 95%CI: -2.3, -1.6). Dementia incidence did not differ among beneficiaries with and without breast cancer. ConclusionsDementia risk may be increased among people with HIV with certain cancers, including AIDS-defining cancers. Dementia risk appears to vary by cancer type and age at diagnosis.